170 related articles for article (PubMed ID: 27462786)
21. Ligand stimulation of CD95 induces activation of Plk3 followed by phosphorylation of caspase-8.
Helmke C; Raab M; Rödel F; Matthess Y; Oellerich T; Mandal R; Sanhaji M; Urlaub H; Rödel C; Becker S; Strebhardt K
Cell Res; 2016 Aug; 26(8):914-34. PubMed ID: 27325299
[TBL] [Abstract][Full Text] [Related]
22. Early clinical outcomes of anal squamous cell carcinoma treated with concurrent chemoradiotherapy with 5-Fluorouracil plus mitomycin C in Japanese patients: experience at a single institution.
Satake H; Yoshino T; Sasaki T; Bando H; Yoda Y; Ikematsu H; Kojima T; Fuse N; Zenda S; Doi T; Kaneko K; Ohtsu A
Jpn J Clin Oncol; 2012 Sep; 42(9):861-4. PubMed ID: 22717459
[TBL] [Abstract][Full Text] [Related]
23. Mitomycin or cisplatin chemoradiation with or without maintenance chemotherapy for treatment of squamous-cell carcinoma of the anus (ACT II): a randomised, phase 3, open-label, 2 × 2 factorial trial.
James RD; Glynne-Jones R; Meadows HM; Cunningham D; Myint AS; Saunders MP; Maughan T; McDonald A; Essapen S; Leslie M; Falk S; Wilson C; Gollins S; Begum R; Ledermann J; Kadalayil L; Sebag-Montefiore D
Lancet Oncol; 2013 May; 14(6):516-24. PubMed ID: 23578724
[TBL] [Abstract][Full Text] [Related]
24. Chemoradiotherapy for anal squamous cell carcinoma.
Houlihan OA; O'Neill BD
Surgeon; 2016 Aug; 14(4):202-12. PubMed ID: 27118047
[TBL] [Abstract][Full Text] [Related]
25. The prognostic significance of pretreatment leukocytosis in patients with anal cancer treated with radical chemoradiotherapy or radiotherapy.
Banerjee R; Roxin G; Eliasziw M; Joseph K; Maclean A; Buie WD; Doll C
Dis Colon Rectum; 2013 Sep; 56(9):1036-42. PubMed ID: 23929012
[TBL] [Abstract][Full Text] [Related]
26. Significance of Co-expression of Epidermal Growth Factor Receptor and Ki67 on Clinical Outcome in Patients With Anal Cancer Treated With Chemoradiotherapy: An Analysis of NRG Oncology RTOG 9811.
Doll CM; Moughan J; Klimowicz A; Ho CK; Kornaga EN; Lees-Miller SP; Ajani JA; Crane CH; Kachnic LA; Okawara GS; Berk LB; Roof KS; Becker MJ; Grisell DL; Ellis RJ; Sperduto PW; Marsa GW; Guha C; Magliocco AM
Int J Radiat Oncol Biol Phys; 2017 Mar; 97(3):554-562. PubMed ID: 28126304
[TBL] [Abstract][Full Text] [Related]
27. Salvage surgery for residual primary and locally recurrent anal squamous cell carcinoma after chemoradiotherapy in HIV-positive individuals.
Cunin L; Alfa-Wali M; Turner J; Bower M; Ion L; Allen-Mersh T
Ann Surg Oncol; 2014 Feb; 21(2):527-32. PubMed ID: 24242676
[TBL] [Abstract][Full Text] [Related]
28. [Four cases of anal squamous cell carcinoma treated by chemoradiotherapy].
Sato H; Maeda K; Koide Y; Matsuoka H; Noro T; Honda K; Shiota M; Endo T; Ozeki S; Fukuda M
Gan To Kagaku Ryoho; 2010 Nov; 37(12):2647-9. PubMed ID: 21224667
[TBL] [Abstract][Full Text] [Related]
29. Chemoradiotherapy for squamous cell anal carcinoma: a review of prognostic factors.
Kapacee ZA; Susnerwala S; Wise M; Biswas A; Danwata F; Scott N
Colorectal Dis; 2016 Nov; 18(11):1080-1086. PubMed ID: 27028038
[TBL] [Abstract][Full Text] [Related]
30. Impact of advancing age on treatment and outcomes in anal cancer.
Foo M; Link E; Leong T; Chu J; Lee MT; Chander S; Tran PK; Tomaszewski JM; Michael M; Heriot A; Ngan SY
Acta Oncol; 2014 Jul; 53(7):909-16. PubMed ID: 24456502
[TBL] [Abstract][Full Text] [Related]
31. Twenty-five-year experience with radical chemoradiation for anal cancer.
Tomaszewski JM; Link E; Leong T; Heriot A; Vazquez M; Chander S; Chu J; Foo M; Lee MT; Lynch CA; Mackay J; Michael M; Tran P; Ngan SY
Int J Radiat Oncol Biol Phys; 2012 Jun; 83(2):552-8. PubMed ID: 22019078
[TBL] [Abstract][Full Text] [Related]
32. Prospective evaluation of acute toxicity and quality of life after IMRT and concurrent chemotherapy for anal canal and perianal cancer.
Han K; Cummings BJ; Lindsay P; Skliarenko J; Craig T; Le LW; Brierley J; Wong R; Dinniwell R; Bayley AJ; Dawson LA; Ringash J; Krzyzanowska MK; Moore MJ; Chen EX; Easson AM; Kassam Z; Cho C; Kim J
Int J Radiat Oncol Biol Phys; 2014 Nov; 90(3):587-94. PubMed ID: 25194664
[TBL] [Abstract][Full Text] [Related]
33. Human papillomavirus-related squamous cell carcinoma of the anal canal with papillary features.
Leon ME; Shamekh R; Coppola D
World J Gastroenterol; 2015 Feb; 21(7):2210-3. PubMed ID: 25717259
[TBL] [Abstract][Full Text] [Related]
34. Phase I study of cetuximab in combination with 5-fluorouracil, mitomycin C and radiotherapy in patients with locally advanced anal cancer.
Leon O; Guren MG; Radu C; Gunnlaugsson A; Johnsson A
Eur J Cancer; 2015 Dec; 51(18):2740-6. PubMed ID: 26597443
[TBL] [Abstract][Full Text] [Related]
35. Efficacy and toxicity of chemoradiation in the treatment of HIV-associated anal cancer.
Hauerstock D; Ennis RD; Grossbard M; Evans A
Clin Colorectal Cancer; 2010 Oct; 9(4):238-42. PubMed ID: 20920996
[TBL] [Abstract][Full Text] [Related]
36. Multimodal Therapy of Squamous Cell Carcinoma of the Anus With Distant Metastasis: A Single-Institution Experience.
Evesque L; Benezery K; Follana P; Tuan Falk A; Doyen J; Reure J; Cavaglione G; François E
Dis Colon Rectum; 2017 Aug; 60(8):785-791. PubMed ID: 28682963
[TBL] [Abstract][Full Text] [Related]
37. Outcomes of chemoradiotherapy with 5-Fluorouracil and mitomycin C for anal cancer in immunocompetent versus immunodeficient patients.
Seo Y; Kinsella MT; Reynolds HL; Chipman G; Remick SC; Kinsella TJ
Int J Radiat Oncol Biol Phys; 2009 Sep; 75(1):143-9. PubMed ID: 19203845
[TBL] [Abstract][Full Text] [Related]
38. The Effect of the UK Coordinating Centre for Cancer Research Anal Cancer Trial (ACT1) on Population-based Treatment and Survival for Squamous Cell Cancer of the Anus.
Downing A; Morris EJ; Aravani A; Finan PJ; Lawton S; Thomas JD; Sebag-Montefiore D
Clin Oncol (R Coll Radiol); 2015 Dec; 27(12):708-12. PubMed ID: 26188917
[TBL] [Abstract][Full Text] [Related]
39. [A case of squamous cell carcinoma of the anal cancer with associated human immunodeficiency virus].
Sueda K; Ikenaga M; Miyazaki M; Yasui M; Mishima H; Tsujie M; Omiya H; Miyamoto A; Hirao M; Takami K; Fujitani K; Nakamori S; Yoshida K; Tsujinaka T
Gan To Kagaku Ryoho; 2010 Nov; 37(12):2656-8. PubMed ID: 21224670
[TBL] [Abstract][Full Text] [Related]
40. PET-CT guided SIB-IMRT combined with concurrent 5-FU/MMC for the treatment of anal cancer.
Zimmermann M; Beer J; Bodis S; von Moos R; Vlachopoulou V; Zwahlen DR; Oehler C
Acta Oncol; 2017 Dec; 56(12):1734-1740. PubMed ID: 28557585
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
